Avista Capital Partners

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$55M
Portfolio companies 4
Rounds per year 0.44
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Exits 2
Key employees 3
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Medical Device
  • Drug Delivery
  • Other Devices and Supplies
Summary

In 2005 was created Avista Capital Partners, which is appeared as VC. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.

The top amount of exits for fund were in 2017. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2014. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund. Comparing to the other companies, this Avista Capital Partners performs on 12 percentage points less the average number of lead investments.

The overall number of key employees were 3.

Among the most popular portfolio startups of the fund, we may highlight Braeburn, OptiNose. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Oil and Gas, Natural Resources.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Avista Capital Partners, startups are often financed by WFD Ventures, The Entrepreneurs' Fund, Oxygen House. The meaningful sponsors for the fund in investment in the same round are WFD Ventures, Entrepreneurs Fund, Wellington Capital Management. In the next rounds fund is usually obtained by WFD Ventures, Entrepreneurs Fund, The Entrepreneurs' Fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Avista Capital Partners:
Typical Co-investors
Avista Capital Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Avista Capital Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Active Capital Trust England, London, United Kingdom
Arcano Community of Madrid, Madrid, Spain
Camelot Financial Capital Management -
Charles Schwab California, San Francisco, United States
Coriolis Ventures New York, New York, United States
Glory Technology (H.K) Group Limited -
Hayaat Group Dubai, United Arab Emirates
IBBT iVentures fund -
InFocus Capital Partners Jericho, New York, United States
Jiaxing Sanban Jiapaosi Hao Touzi China, Jiaxing, Zhejiang
Juniper Ventures California, Palo Alto, United States
Koray Spring -
Miyamoto International -
Neon Adventures England, London, United Kingdom
Palmieri Family Trust -
Psion Teklogix Canada, Mississauga, Ontario
Serengeti Capital Accra, Ghana, Greater Accra Region
Sky Blessing Investment -
Unicore Technology Company -
Virginia Research Investment Committee Richmond, United States, Virginia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

SolmeteX

Dental
Waste Management
Water
18 Dec 2020 Massachusetts, United States

Braeburn

Biotechnology
Health Care
Medical Device
Pharmaceutical
$110M10 Jan 2018 Whitemarsh Township, Pennsylvania, United States

OptiNose

Biotechnology
Drug Delivery
Medical Device
Other Devices and Supplies
Pharmaceutical
$37M09 May 2017 Oslo

OptiNose

Biotechnology
Drug Delivery
Medical Device
Other Devices and Supplies
Pharmaceutical
$30M06 Oct 2015 Oslo

OptiNose

Biotechnology
Drug Delivery
Medical Device
Other Devices and Supplies
Pharmaceutical
$35M05 Aug 2014 Oslo

Energy
Natural Resources
Oil and Gas
$130M29 May 2014 Houston, Texas, United States

OptiNose

Biotechnology
Drug Delivery
Medical Device
Other Devices and Supplies
Pharmaceutical
$48M07 Jun 2010 Oslo, Norway

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Avista Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: